Atovaquone and proguanil are usually administered concurrently in therapy for acute uncomplicated malaria caused by Plasmodium falciparum, most especially if the parasite becomes resistant to other forms of treatment such as chloroquine.

Malaria Prevention (Prophylaxis):

The drug combination is also used in malaria prevention, especially when chloroquine-resistant malaria is prevalent. It is recommended for travelers visiting areas with extensive malaria transmission.

Toxoplasmosis:

Sometimes, in rare cases, atovaquone and proguanil are taken together for the treatment of Toxoplasma gondii infections.

Advantages of the Atovaquone-Proguanil Combination

Actively Efficacious Against Drug-Resistant Malaria:

The primary benefit of atovaquone-proguanil is the treatment of malaria caused by the Plasmodium falciparum parasite that is resistant to chloroquine and also sulfadoxine-pyrimethamine.

Convenient Dosage:

The combination is given once a day, therefore, it is easy for patients to be compliant with the treatment course compared to other antimalarial drugs that have many doses daily.

Less Side Effects:

Compared to older antimalarial drugs, atovaquone and proguanil tend to have a better side-effect profile, are fewer gastrointestinal issues and generally mild side effects.

Short Treatment Course:

Together, when administered to cure malaria, this combination treatment is usually required only for a short period, typically 3 days. This makes it very helpful for travelers or patients newly diagnosed with malaria.

Effective Against Malaria:

Atovaquone and proguanil have been shown to be highly effective drugs against malaria, even the drug-resistant forms. Even as such, the combination has been used to prevent malaria in travelers traveling to endemic regions.

Combinations of atovaquone with proguanil exhibit a synergistic effect. In other words, together they are more effective than alone. Drug actions on different life cycle stages of the malaria parasite include: 

Atovaquone: this acts primarily on the mitochondrial electron transport chain of the Plasmodium parasite, stopping the production of energy and replication.

Proguanil: It works by blocking the pathway for folate synthesis, which is essential for the growth and proliferation of the parasite. It also knocks out the liver stage of the parasite’s life cycle.

By this combination, where the attack on the parasite occurs through multiple mechanisms, it discourages the development of resistance and, hence, allows a more holistic approach to the elimination of the parasite in the body.

The combination is mostly tolerable but tends to cause side effects and, in some cases, serious enough to require medical attention. Common side effects include the following;

Gastrointestinal Issues:

The side effect often experienced is nausea, vomiting, pain in the stomach or abdomen, and diarrhea, more so if taken without food. Intake of the medication with food can be helpful in preventing such side effects.

Headache:

In some patients, headaches also appear on the course of treatment.

Skin rashes-some mild and transitory, but serious ones in some rare instances.

Changes in Liver Function:

Abnormality in the liver enzymes may arise from the long-term therapy with the atovaquone-proguanil combination, and the liver should be checked regarding its function with the long term therapy.

Dizziness or Fatigue:

Some patients can feel drowsy or dizzy when getting up from a lying position, especially .

Serious Adverse Reactions:

Although very rare, serious allergic reactions involving facial swelling, lips, tongue, or throat may occur. With symptoms of a serious allergic reaction, see a doctor immediately.

Pregnancy and Breast-feeding

Atovaquone-proguanil has not been established for safety during pregnancy. It is classified as Category C, meaning in the animal studies it could have caused harm to the fetus, but its potential benefits for treating malaria might outweigh the risks for some patients.

This drug should only be used during pregnancy if potencies outweigh risks to the fetus. Pregnant women or those planning to become pregnant should take this risk into considerations and discuss with their healthcare providers.

Both drugs excrete in breast milk, hence caution is recommended to breastfeeding mothers. This drug should be used only when necessary, and the infant should be monitored for side effects.

1. Rifampin: Rifampin, an antibiotic, can reduce the effectiveness of Atovaquone and Proguanil by increasing the metabolism of Atovaquone, leading to lower blood levels of the drug.
2. Warfarin: Atovaquone and Proguanil may increase the anticoagulant effect of warfarin, potentially raising the risk of bleeding. Monitoring of INR levels is advised.
3. Tetracycline Antibiotics: Tetracycline antibiotics (e.g., doxycycline) can decrease the effectiveness of Atovaquone by interfering with its absorption and bioavailability, potentially reducing its antimalarial activity.
4. Antacids: Antacids containing aluminum or magnesium may decrease the absorption of Atovaquone, leading to reduced effectiveness in treating or preventing malaria. It’s recommended to space the use of antacids and Atovaquone.

Treatment for Malaria

Adults and children over 11 years: 4 tablets atovaquone-proguanil (250 mg/100 mg) once a day for 3 days.

Children (5 to 11 years): Dosage is weight-based; typical range is 1 to 3 tablets per day.

Malaria Prophylaxis (Prevention):

Adults and children over 11 years: One tablet per day, starting 1 to 2 days before travel to an area with malaria and continuing for 7 days after leaving the area.

Children (5 to 11 years): One tablet daily, beginning 1 to 2 days before travel and continuing for 7 days after leaving an area.

Patients should take the tablets with food, especially a meal high in fat, to enhance absorption of atovaquone and proguanil.

Availability Atovaquone and proguanil: Prescription only. Patients should consult their healthcare provider to obtain a prescription for the proper treatment for the patient’s condition and to discuss dosing information.

1. What is Atovaquone and Proguanil?

   • Atovaquone and Proguanil is an antimalarial medication used for the prevention and treatment of malaria.

2. How does Atovaquone and Proguanil work?

   • Atovaquone works by inhibiting mitochondrial respiration in malaria parasites, while Proguanil interferes with their folate metabolism, leading to parasite death.

3. Who should take Atovaquone and Proguanil?

   • It is typically prescribed for travelers to malaria-endemic areas and for individuals diagnosed with malaria.

4. What is the recommended dosage for prophylaxis?

   • For prevention, the usual dosage is one tablet daily, starting 1-2 days before travel and continuing for 7 days after leaving the area.

5. What is the recommended dosage for treatment of malaria?

   • For treatment, the recommended dosage is four tablets (total of 1000 mg Atovaquone and 400 mg Proguanil) taken once a day for three days.

6. Are there any side effects associated with Atovaquone and Proguanil?

   • Common side effects include nausea, vomiting, abdominal pain, and headache. Serious side effects are rare but can occur.

7. Can I take Atovaquone and Proguanil if I am pregnant?

   • Atovaquone and Proguanil should only be used during pregnancy if the benefits outweigh the risks. Always consult your doctor.

8. Can Atovaquone and Proguanil be used alongside other medications?

   • It may interact with certain medications, including rifampicin and tetracycline. It’s essential to inform your healthcare provider about all medications you are taking.

9. What should I do if I miss a dose?

   • If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose and resume your regular schedule.

10. Is it safe to consume alcohol while taking Atovaquone and Proguanil?

    • While there is no specific interaction, it’s generally advised to limit alcohol intake during treatment due to potential side effects.

11. How does Atovaquone and Proguanil compare to other malaria medications?

    • It is effective and has fewer side effects compared to some alternatives like chloroquine and mefloquine, but resistance can occur in some areas.

12. What should I do if I experience severe side effects?

    • Seek medical attention immediately if you develop severe side effects such as rash, difficulty breathing, or swelling of the face/lips.

13. Can children take Atovaquone and Proguanil?

    • Yes, it can be prescribed for children over the age of 11 kg, but dosing should be determined by a healthcare provider.

14. How long is Atovaquone and Proguanil effective after intake?

    • It provides protection for 24 hours after each dose, so adherence to the dosing schedule is crucial for effectiveness.

15. Are there any dietary restrictions while taking Atovaquone and Proguanil?

    • It is recommended to take the medication with food to enhance absorption and reduce gastrointestinal side effects.

16. Can I take Atovaquone and Proguanil if I have liver or kidney issues?

    • Patients with liver or kidney impairment should use Atovaquone and Proguanil with caution and under medical supervision.

17. How should Atovaquone and Proguanil be stored?

    • Store it in a cool, dry place away from direct sunlight and out of reach of children.

18. Is Atovaquone and Proguanil effective against all types of malaria?

    • It is effective against Plasmodium falciparum and Plasmodium vivax but is not recommended for treatment of severe malaria.

19. What should I do if I develop a fever while taking Atovaquone and Proguanil?

    • Contact your healthcare provider if you experience a fever, as it may indicate a treatment failure or other illness.

20. Where can I find more information about Atovaquone and Proguanil?

    • For more information, consult your healthcare provider or refer to reliable medical resources such as the CDC or WHO.